Clinical Trials Directory

Trials / Sponsors / TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
UnknownSafety and Efficacy Study of SHAPE Gel in Alopecia Areata
Alopecia Areata
Phase 22017-02-01
TerminatedPhase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B
Hepatitis B
Phase 12014-11-01
UnknownEfficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma
Cutaneous T-Cell Lymphoma (CTCL)
Phase 22014-11-01
TerminatedStudy of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML)
Phase 22014-06-01
CompletedStudy of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Relapsed Epithelial Ovarian Cancer, Relapsed Primary Peritoneal Cancer, Relapsed Fallopian Tube Cancer
Phase 12013-11-01
CompletedBirinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine
Myelodysplastic Syndrome
Phase 1 / Phase 22013-06-01
CompletedSHP-141C in Plaque Type Psoriasis
Plaque Type Psoriasis
Phase 12012-09-01
CompletedSafety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphom
Lymphoma, T-Cell, Cutaneous
Phase 12011-11-01
CompletedDose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or M
Cancer
Phase 1 / Phase 22010-10-01
CompletedDose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
Cancer
Phase 12009-11-01